Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Depletion and recovery of IgG following treatment with Rozanoliximab and Imlifidase in pigtail macaques.

Depletion and recovery of IgG following treatment with Rozanoliximab and Imlifidase in pigtail macaques.

Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025

Pharmacovigilance analysis of FcRn antagonists in the treatment of myasthenia gravis: A disproportionality analysis based on the FAERS database.

Pharmacovigilance analysis of FcRn antagonists in the treatment of myasthenia gravis: A disproportionality analysis based on the FAERS database.

Journal: Human vaccines & immunotherapeutics
Published: November 13, 2025

Rozanolixizumab as rescue therapy in triple-seronegative refractory generalized myasthenia gravis.

Rozanolixizumab as rescue therapy in triple-seronegative refractory generalized myasthenia gravis.

Journal: Immunological medicine
Published: November 10, 2025

Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape.

Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape.

Journal: Expert opinion on emerging drugs
Published: September 23, 2025

Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study.

Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study.

Journal: Annals of the rheumatic diseases
Published: August 26, 2025

Management of Myasthenic Crisis and Emerging Roles of Molecularly Targeted Therapies: A Narrative Review.

Management of Myasthenic Crisis and Emerging Roles of Molecularly Targeted Therapies: A Narrative Review.

Journal: Neurology international
Published: August 07, 2025

Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study.

Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study.

Journal: Journal of neurology
Published: July 23, 2025

Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study.

Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study.

Journal: Journal of neurology
Published: July 22, 2025

Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network.

Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network.

Journal: Frontiers in immunology
Published: July 21, 2025

Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report.

Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report.

Journal: The Neurohospitalist
Published: July 20, 2025

From promise to practice: evaluating the clinical impact of FcRn inhibition in IgG-mediated autoimmune rheumatic diseases.

From promise to practice: evaluating the clinical impact of FcRn inhibition in IgG-mediated autoimmune rheumatic diseases.

Journal: Frontiers in immunology
Published: June 30, 2025

A comprehensive review of the treatment options in myasthenia gravis.

A comprehensive review of the treatment options in myasthenia gravis.

Journal: Disease-a-month : DM
Published: June 21, 2025
Showing 1-12 of 77

Last Updated: 01/07/2026